Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30

$12.95−0.45 (-3.36%)

Close on Nov 12, 2026Market cap $908.68MP/E 323.8Yield –

Pharming operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was 6.9%, against -2.9% the year before. The highest annual figure on record is 36.0% in fiscal 2019.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	6.9%	+9.8
FY2024	Dec 31, 2024	-2.9%	−0.7
FY2023	Dec 31, 2023	-2.2%	−11.1
FY2022	Dec 31, 2022	8.9%	+2.0
FY2021	Dec 31, 2021	6.8%	−29.1
FY2020	Dec 31, 2020	35.9%	−0.1
FY2019	Dec 31, 2019	36.0%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PHAR.

Revenue growth26.6% · median 38.4%

Gross margin87.9% · median 87.4%

Operating margin6.9% · median -63.0%

Net margin0.8% · median -44.9%

Advertisement
300 × 250

See a number that looks wrong?